COVID-19: A Review of the Available Evidence Regarding Pediatric Population

COVID-19: una revisión de la evidencia en el ámbito pediátrico

In the context of the COVID-19 pandemic, the adequate selection and appropriate use of previously acquired knowledge from similar historical situations and the one acquired lately amid the pandemic is vital to guarantee correct decision-making regarding the prevention, management and treatment of this disease in the pediatric population. Since the beginning of 2020, attention has shifted to controlling the pandemic and managing patients with this disease, the majority being those in the adult population. However, more severe courses of the disease have recently been observed in pediatric patients, and what was initially considered to be a harmless pathology in this population has generated greater alerts due to the presence of severe complications. Therefore, this review seeks to determine the latest prevention, diagnosis and treatment strategies endorsed and supported by scientific evidence, in order to provide the necessary tools to guarantee proper management and to reduce, as far as possible, the fatal outcomes in the pediatric population.

1. Millán-Oñate J, Rodriguez-Morales AJ, Camacho-Moreno G, Mendoza-Ramírez H, Rodríguez-Sabogal IA, Álvarez-Moreno C. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19). Infectio. 15 de abril de 2020;24(3):187.

2. COVID-19 Map FAQ [Internet]. Johns Hopkins Coronavirus Resource Center. [citado 28 de junio de 2020]. Disponible en: https://coronavirus.jhu.edu/map-faq

3. Ludvigsson JF. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. junio de 2020;109(6):1088-95.

4. Zimmermann P, Curtis N. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. Pediatr Infect Dis J. mayo de 2020;39(5):355-68.

5. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. abril de 2020;S1473309920302875.

6. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 7 de abril de 2020;323(13):1239.

7. Zachariah P, Johnson CL, Halabi KC, Ahn D, Sen AI, Fischer A, et al. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children’s Hospital in New York City, New York. JAMA Pediatr. 3 de junio de 2020;e202430.

8. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. junio de 2020;20(6):689-96.

9. Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr [Internet]. 11 de mayo de 2020 [citado 28 de junio de 2020]; Disponible en: https://jamanetwork.com/journals/jamapediatrics/fullarticle/2766037

10. Dechartres A, Boutron I, Trinquart L, Charles P, Ravaud P. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann Intern Med. 2011;155(1):39-51.

11. McCormick M. Rats, Communications, and Plague: Toward an Ecological History. J Interdiscip Hist. julio de 2003;34(1):1-25.

12. Wolfe MK, Gallandat K, Daniels K, Desmarais AM, Scheinman P, Lantagne D. Handwashing and Ebola virus disease outbreaks: A randomized comparison of soap, hand sanitizer, and 0.05% chlorine solutions on the inactivation and removal of model organisms Phi6 and E. coli from hands and persistence in rinse water. Cameron DW, editor. PLOS ONE. 23 de febrero de 2017;12(2):e0172734.

13. Malavazos AE, Corsi Romanelli MM, Bandera F, Iacobellis G. Targeting the Adipose Tissue in COVID‐19. Obesity. julio de 2020;28(7):1178-9.

14. Butler MJ, Barrientos RM. The impact of nutrition on COVID-19 susceptibility and long-term consequences. Brain Behav Immun. julio de 2020;87:53-4.

15. Elmadfa I, Meyer AL. The Role of the Status of Selected Micronutrients in Shaping the Immune Function. Endocr Metab Immune Disord - Drug Targets. 11 de noviembre de 2019;19(8):1100-15.
16. Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. mayo de 2020;92(5):4
79-90.
17. Gasmi A, Noor S, Tippairote T, Dadar M, Menzel A, Bjørklund G. Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic. Clin Immunol. junio de 2020;215:108409.

18. Semba RD, Tang AM. Micronutrients and the pathogenesis of human immunodeficiency virus infection. Br J Nutr. marzo de 1999;81(3):181-9.

19. Barazzoni R, Bischoff SC, Breda J, Wickramasinghe K, Krznaric Z, Nitzan D, et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. junio de 2020;39(6):1631-8.

20. Naja F, Hamadeh R. Nutrition amid the COVID-19 pandemic: a multi-level framework for action. Eur J Clin Nutr [Internet]. 20 de abril de 2020 [citado 28 de junio de 2020]; Disponible en: http://www.nature.com/articles/s41430-020-0634-3

21. Mullard A. COVID-19 vaccine development pipeline gears up. The Lancet. junio de 2020;395(10239):1751-2.

22. Sun J, Zhuang Z, Zheng J, Li K, Wong RL-Y, Liu D, et al. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. junio de 2020;S0092867420307418.

23. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 23 de abril de 2020;382(17):1663-5.

24. Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr [Internet]. 22 de abril de 2020 [citado 28 de junio de 2020]; Disponible en: https://jamanetwork.com/journals/jamapediatrics/fullarticle/2765169

25. China National Clinical Research Center for Respiratory Diseases, National Center for Children’s Health, Beijing, China, Group of Respirology, Chinese Pediatric Society, Chinese Medical Association, Chinese Medical Doctor Association Committee on Respirology Pediatrics, China Medicine Education Association Committee on Pediatrics, Chinese Research Hospital Association Committee on Pediatrics, et al. Updated diagnosis, treatment and prevention of COVID-19 in children: experts’ consensus statement (condensed version of the second edition). World J Pediatr. junio de 2020;16(3):232-9.

26. Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C, et al. Multisystem Inflammatory Syndrome in Children During the Coronavirus 2019 Pandemic: A Case Series. J Pediatr Infect Dis Soc. 28 de mayo de 2020;piaa069.

27. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review | Clinical Pharmacy and Pharmacology | JAMA | JAMA Network [Internet]. [citado 29 de junio de 2020]. Disponible en: https://jamanetwork.com/journals/jama/fullarticle/2764727

28. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report | medRxiv [Internet]. [citado 29 de junio de 2020]. Disponible en: https://www.medrxiv.org/content/10.1101/2020.06.22.20137273v1